Pharmacogenetic Analysis of INT 0144 Trial: Association of Polymorphisms with Survival and Toxicity in Rectal Cancer Patients Treated with 5-FU and Radiation

MLA

Kathleen D. Danenberg, et al. “Pharmacogenetic Analysis of INT 0144 Trial: Association of Polymorphisms with Survival and Toxicity in Rectal Cancer Patients Treated with 5-FU and Radiation.” Clinical Cancer Research, vol. 21, Mar. 2015, pp. 1583–90. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....921456dcc8e00fbbd1ea27cb22d95015&authtype=sso&custid=ns315887.

APA

Kathleen D. Danenberg, Christine Cripps, James A. Martensen, Robert J. Mayer, Thomas Winder, Tyvin A. Rich, Stephen R. Smalley, Wu Zhang, Al B. Benson, Heinz-Josef Lenz, Jacqueline Benedetti, Cathryn Rankin, Charles D. Blanke, Pierre Oliver Bohanes, Karen W. Makar, & Cornelia M. Ulrich. (2015). Pharmacogenetic Analysis of INT 0144 Trial: Association of Polymorphisms with Survival and Toxicity in Rectal Cancer Patients Treated with 5-FU and Radiation. Clinical Cancer Research, 21, 1583–1590.

Chicago

Kathleen D. Danenberg, Christine Cripps, James A. Martensen, Robert J. Mayer, Thomas Winder, Tyvin A. Rich, Stephen R. Smalley, et al. 2015. “Pharmacogenetic Analysis of INT 0144 Trial: Association of Polymorphisms with Survival and Toxicity in Rectal Cancer Patients Treated with 5-FU and Radiation.” Clinical Cancer Research 21 (March): 1583–90. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....921456dcc8e00fbbd1ea27cb22d95015&authtype=sso&custid=ns315887.